Boston, MA4 Active Studies

Neuromyelitis Optica Clinical Trials in Boston, MA

Find 4 actively recruiting neuromyelitis optica clinical trials in Boston, MA. Connect with local research sites and explore new treatment options.

4
Active Trials
4
Sponsors
858
Enrolling

Recruiting Neuromyelitis Optica Studies in Boston

NCT07010302Recruiting

Rituximab Versus Ravulizumab, Inebilizumab, Satralizumab, and Eculizumab in NMOSD

Neuromyelitis Optica Spectrum Disorder (NMOSD) is a rare autoimmune condition that mainly affects the eyes and spinal cord, causing serious symptoms such as vision loss, paralysis, and severe pain. Th...

Boston, MAPHASE4540 participantsMassachusetts General Hospital
View Study Details
NCT05966467Recruiting

Registry of Patients With AQP4+ NMOSD Treated With Alexion C5 Inhibitor Therapies

Long-term, multicenter, multinational, observational, registry of patients with AQP4+ NMOSD that is designed to collect data on clinical outcomes and safety in patients prescribed Alexion C5 inhibitor...

Boston, MA200 participantsAlexion Pharmaceuticals, Inc.
View Study Details
NCT05566769Recruiting

Performance and Safety of a Digital Tool for Unsupervised Self-assessment of NMOSD

NMOSDCopilot is a digital tool developed for the self-assessment of Neuromyelitis Optica Spectrum Disorder symptoms that impact patients' functioning and quality of life. It has been co-designed with ...

Boston, MANA103 participantsAd scientiam
View Study Details
NCT05549258Recruiting

Study of Inebilizumab in Pediatric Subjects With Neuromyelitis Optica Spectrum Disorder

A Phase 2, open-label, multicenter study to evaluate the pharmacokinetics (PK), pharmacodynamics (PD), and safety of inebilizumab in eligible pediatric participants 2 to \< 18 years of age with recent...

Boston, MAPHASE215 participantsAmgen
View Study Details

About Neuromyelitis Optica Clinical Trials in Boston

Neuromyelitis optica spectrum disorder (NMOSD) is a rare autoimmune disease that primarily attacks the optic nerves and spinal cord, causing vision loss and paralysis. It is distinct from multiple sclerosis and often involves aquaporin-4 antibodies. Treatment includes immunosuppressive therapies and biologics.

There are currently 4 neuromyelitis optica clinical trials recruiting participants in Boston, MA. These studies are seeking a combined 858 participants. Research is being sponsored by Massachusetts General Hospital, Alexion Pharmaceuticals, Inc., Ad scientiam and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Neuromyelitis Optica Clinical Trials in Boston — FAQ

Are there neuromyelitis optica clinical trials in Boston?

Yes, there are 4 neuromyelitis optica clinical trials currently recruiting in Boston, MA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Boston?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Boston research site will contact you about next steps.

Are clinical trials in Boston free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Boston studies also compensate for your time and travel.

What neuromyelitis optica treatments are being tested?

The 4 active trials in Boston are testing new therapies including novel drugs, biologics, and treatment approaches for neuromyelitis optica.

Data updated October 18, 2026 from ClinicalTrials.gov